Quantum BioPharma understands that Quantum BioPharma shareholder Paul Durkacz has filed a class action lawsuit alleging that investors in Quantum BioPharma were the victims of stock manipulation. The suit alleges that between January 6, 2021, and October 15, 2025, shareholders who sold securities of Quantum Biopharma Ltd., formerly known as FSD Pharma Inc., were significantly and materially harmed.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum BioPharma Moves to Lead Class Action Over Alleged Stock Manipulation by Canadian Banks
- Quantum BioPharma Closes Private Placement, Enhances Governance
- Quantum BioPharma Ends Market Offering Agreement
- Quantum BioPharma’s Lawsuit Highlighted in CTV’s W5 Series
- Quantum BioPharma announces airing of news segment on manipulation lawsuit